ESR1 and breast cancer: Moreover, in a comprehensive review in breast cancer gene-expression based assays by Prat et al. it is shown that the concordance between two different ER/PR testing methods based on IHC falls below the highest levels of reproducibility/concordance expected in daily clinical use [16].